[ESPR] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
01-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 14.53%
YoY- 1.12%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 25,786 24,329 18,818 18,980 18,841 18,836 15,401 41.13%
PBT -49,935 -61,719 -55,487 -55,117 -66,324 -56,731 -65,119 -16.26%
Tax -51 27,501 12,974 13,494 13,948 13,742 13,430 -
NP -49,935 -89,220 -68,461 -68,611 -80,272 -70,473 -65,119 -16.26%
Tax Rate - - - - - - - -
Total Cost 75,721 113,549 87,279 87,591 99,113 89,309 80,520 -4.02%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -193.65 -366.72 -363.81 -361.49 -426.05 -374.14 -422.82 -40.66%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.46 -1.14 -0.93 -1.01 -1.27 -1.16 -1.77 -59.37%
EPS Diluted -0.46 -1.14 -0.93 -1.01 -1.27 -1.16 -1.77 -59.37%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.